| Document |
Document Title |
|
WO/2023/212255A9 |
This invention relates to methods for separating, isolating and/or enriching extracellular matrix bodies in a biological fluid. More particularly, this invention discloses methods for isolating and detecting extracellular matrix bodies f...
|
|
WO/2024/009413A1 |
[Problem] To provide a specimen collection device and a specimen collection kit that are capable of restricting a specimen from flowing out into a collection container. [Solution] A specimen collection device according to an embodiment o...
|
|
WO/2024/008992A1 |
The present invention relates to an electrochemical method for detecting, identifying and quantifying ions and nutrients dissolved in water by means of voltammetry, and equipment for carrying out said method, the method comprising: a ste...
|
|
WO/2024/009263A1 |
A method of operating a sensor system with a non-invasive sensor having a plurality of antenna to detect analytes in a target includes determining a first detection frequency sweep and determining a second detection frequency sweep. The ...
|
|
WO/2024/010961A1 |
The presently subject matter relates to electrochemical methods for detecting cocaine in samples, especially powder samples, and is suitable for forensic use in the field when rapid detection is desired, and the sample contains cocaine a...
|
|
WO/2024/009208A1 |
After traditional electrochemical measurement techniques, a new technique for oxygen concentration determination has been developed with the invention of the Luminescent Dissolved Oxygen (LDO) probe. This method is based on the reduction...
|
|
WO/2024/010373A1 |
The present invention relates to antibodies that bind to an IgE-dependent histamine-releasing factor (HRF) and uses thereof. It has been confirmed that the anti-HRF antibodies according to the present invention inhibit HRF activity by bi...
|
|
WO/2024/008796A1 |
The present invention relates to a sandwich immunoassay for detecting in a biological sample cross-linked Collagen Type V, and its use in identifying patients with conditions associated with fibrosis, such as ankylosing spondylitis, infl...
|
|
WO/2024/011249A1 |
The present disclosure provides compositions, methods, and kits for detecting guaiacol-producing microorganisms, in particular, Thermophilic Acidophilic Bacteria (TAB) in foodstuff. In one example, a method comprises: (a) contacting a se...
|
|
WO/2024/008782A1 |
The invention relates to an in vitro or ex vivo method for determining the risk of death in a subject infected with a respiratory virus, for example SARS-CoV-2, comprising a measurement, in a biological sample of said subject, of the lev...
|
|
WO/2024/009184A1 |
A method for mass spectrometric analysis of a peptide having at least one fragile moiety includes using electrospray ionization to generate a negatively charged ion of said peptide, trapping and cooling the negatively charged peptide ion...
|
|
WO/2024/010058A1 |
In this information processing method, an information processing device executes: a process for acquiring, from a plant to which is imparted a material having an action for enhancing durability against non-biological stress, measurement ...
|
|
WO/2024/009302A1 |
The present disclosure provides diagnostic methods, compositions and kits for detecting ovarian cancer in a subject, specifically, High grade ovarian cancer, more specifically in genetically predisposed patients. In some embodiments, the...
|
|
WO/2024/010921A1 |
A method of making a tissue reference control block is disclosed wherein cancer cells are selected with a known positivity or negativity for a specific marker and cancer cells are grown to a certain phase. The cancer cells are screened f...
|
|
WO/2024/008094A1 |
Provided are an anti-CD20-antibody monoclonal antibody and a use thereof. The monoclonal antibody targeting CD20 antibodies has high specificity and strong affinity. Provided is a CD20 CAR-T cell detection reagent which can target extrac...
|
|
WO/2024/010479A1 |
The present invention discloses high α-tubulin acetylation as a biomarker for cancer cell response to taxol. In one embodiment the present invention refers to a method for predicting prognosis of treatment with taxol, taxanes and other ...
|
|
WO/2024/010866A1 |
Disclosed herein include methods, compositions, and kits suitable for use in reducing or preventing oxidative stress and/or reductive stress. In some embodiments, the method comprises contacting a redox-sensitive composition with an effe...
|
|
WO/2024/006764A1 |
A biotechnological chemically induced dimerization (CID) tool with potential technological and therapeutic applications thereof. These CID systems are used in biological research to control numerous outputs in living organisms, such as i...
|
|
WO/2024/005055A1 |
Provided is a qualitative or quantitative test method for detection target substances contained in a specimen, said test method comprising a preparation step for preparing a test sample from the specimen and a test step for testing at le...
|
|
WO/2024/000077A1 |
Systems and methods for identifying a peptide for a query spectrum. The methods can involve receiving one or more parameters of a query spectrum; generating one or more candidate peptide sequences based on the one or more parameters of t...
|
|
WO/2024/003087A1 |
The present application relates to dyes containing fused tetracyclic bis-boron containing heterocycle and their uses as fluorescent labels. These dyes may be used as fluorescent labels for nucleotides in nucleic acid sequencing applicati...
|
|
WO/2024/003825A1 |
The present invention relates to a method of analysis for estimation of relative potency of antibody of interest using beta-hexosaminidase degranulation in human cell line. The present invention relates to characterization of functional ...
|
|
WO/2024/002724A1 |
The invention relates to a material for quantitatively removing carbon dioxide from a gas stream. The material comprises a mixture of sodium hydroxide, calcium hydroxide and at least one desiccant, the desiccant being a molecular sieve. ...
|
|
WO/2024/004523A1 |
The present invention provides a colorectal cancer biomarker capable of simply and non-invasively determining the presence or absence of colorectal cancer with excellent sensitivity and specificity. The colorectal cancer biomarker acco...
|
|
WO/2024/003617A2 |
Provided herein are methods for determining whether a disorder is susceptible to treatment with a plasma kallikrein inhibitor and methods for identifying a subject as a candidate for treatment with a plasma kallikrein inhibitor. Provided...
|
|
WO/2024/007031A1 |
Cannabinoids are a promising and potent class of agents in the management of pain, and preclinical studies in rodent models suggest that cannabinoids may be particularly potent in relieving neuropathic pain. Despite the potential benefit...
|
|
WO/2024/000417A1 |
A microfluidic chip, and a test system, a test method, and a preparation method thereof. A pressing device for a microfluidic chip comprises a cover plate, a base plate and a probe assembly. The base plate and the cover plate are arrange...
|
|
WO/2024/003908A1 |
A method and respective system are described. The method provides classification of cannabis inflorescence, and comprising: grinding said cannabis inflorescence; and determining a spectrogram of ground cannabis inflorescence; and providi...
|
|
WO/2024/004580A1 |
[Problem] To provide: a novel pathological marker useful in testing disease progression toward vasculitis and in testing the risk of COVID-19 becoming severe; and a means, using the marker, of testing disease progression toward vasculiti...
|
|
WO/2024/006214A1 |
The method may comprise receiving historical data (e.g., mineralogy data, irrigation data, raffinate data, heat data, lift height data, geographic data on ore placement and/or blower data); training a predictive model using the historica...
|
|
WO/2024/005695A1 |
An arrangement (100) arranged to determine quality of a lateral flow stick (110b) arranged on a carrier (120), for determining a biomarker of milk of an animal (301). The arrangement (100) comprises a camera (130) capturing an image (200...
|
|
WO/2024/004917A1 |
A nucleic acid that has been amplified in a reaction solution is detected easily and at good sensitivity. The detection system comprises a reaction unit, having an amplification unit that subjects the nucleic acid to an amplification rea...
|
|
WO/2024/003538A1 |
Provided herein are methods, and compositions for the synthesis of proteins. The methods are applicable to synthesis of proteins on a microfluidic device and assays using the expressed proteins.
|
|
WO/2024/003171A1 |
The invention relates to methods for determining the concentration of an analyte in a sample obtained from processing of blood-derived plasma, the method comprising applying a light source in the near-infrared spectrum to a test sample o...
|
|
WO/2024/002576A1 |
The disclosure refers to reagents, kits and methods for detecting anti-PF4 antibodies and diagnosing thrombotic events not induced by heparin, including vaccine-induced thrombotic thrombocytopenia. The method provided by the disclosure c...
|
|
WO/2024/004648A1 |
[Problem] A mineralocorticoid receptor (MR) is activated due to various pathoses, and the excessive activation thereof is a risk factor of the onset of cerebrocardiovascular diseases. However, since there are no indicators for directly e...
|
|
WO/2024/004981A1 |
[Problem] To provide: a collagen-rich organic composition; a biomaterial using the collagen-rich organic composition as a starting material; a biomaterial or other products containing collagen as a main ingredient; a method for producing...
|
|
WO/2024/003131A1 |
The present invention relates to an agent that inhibits the expression or activity of the G Protein-Coupled Receptor 182 (GPR182) protein for use in the treatment or prevention of a pathological condition selected from myocardial infarct...
|
|
WO/2024/006734A1 |
The present disclosure relates generally to the field of immunology, and particularly relates to methods useful for preparing major histocompatibility complex (MHC) multimer reagents and methods for using the same for characterization of...
|
|
WO/2024/000039A1 |
An apparatus (10) for visual inspection, the apparatus (10) comprising a receiving means (14) configured to receive a sample of particulates and an imagery means (18) configured to capture imagery of the sample. A method for visual inspe...
|
|
WO/2024/003769A1 |
The present invention relates to a ready-to-use kit for the early diagnosis of tumors by the analysis of a sample of a biological liquid and its use for the early diagnosis of tumors.
|
|
WO/2024/003093A1 |
The present invention provides a method for estimating a total porosity of rock from a 3D image. The image is segmented to identify primary and secondary porosity. For primary porosity, segmentation identifies resolved pores and solid ma...
|
|
WO/2024/000008A1 |
The present disclosure relates generally to methods and test kits for identifying SNPs associated with desirable meat eating quality traits in ovine animals. In particular, the present disclosure relates to a SNP-based diagnostic test an...
|
|
WO/2024/005001A1 |
[Problem] To provide a testing method that can detect mild cognitive impairment (MCI) and a measurement reagent for use therein. [Solution] The disclosed MCI testing method includes a measurement step for measuring the hydroxyl radical s...
|
|
WO/2024/006875A1 |
An apparatus for making isotopic ethane measurements of a gas sample includes a tunable infrared laser configured to emit an infrared laser beam; an infrared sensor configured to receive the infrared laser beam; a gas cell deployed in a ...
|
|
WO/2024/006494A1 |
Examples are directed to rapid detection test (RDT) devices, apparatuses, and methods of forming RDT devices and/or apparatuses that include detection particles preloaded in a test region. An example RDT apparatus includes a substrate, a...
|
|
WO/2024/002252A1 |
Provided are an anti-Trop2 nanobody and use thereof. Also provided is a Trop2-binding molecule, comprising an anti-Trop2 nanobody or an antigen-binding fragment thereof. Complementarity determining regions CDRs of the anti-Trop2 nanobody...
|
|
WO/2024/006520A1 |
Provided herein are per- and polyfluoroalkyl compound (PFAS) binding proteins, including anti-PFAS antibodies and biosimilars thereof, and uses of the compositions for detecting PFAS.
|
|
WO/2024/005121A1 |
This calibration method is for calibrating a mass spectrum for mass spectrometry of a microbial sample containing a substance to be analyzed, i.e. molecules to be analyzed, said calibration method including: a step (S31) of acquiring a m...
|
|
WO/2024/005909A1 |
Radio Frequency Identification (RFID) tags having functionalized carbon nanotubes (CNTs) engineered to change in resistance when exposed to a variety of analytes to provide an inexpensive framework for distributed sensing. For example, a...
|
